US FDA approves Jazz Pharma's drug for rare brain tumor - Reuters

Reuters | Aug. 6, 2025, 4:05 p.m. | Original
US FDA approves Jazz Pharma's drug for rare brain tumor Reuters
Nasdaq leads gains on Wall Street, helped by Apple - Reuters Duolingo raises 2025 revenue forecast as AI tools boost user engagement - Reuters